PURPOSE: The study investigates the effects of genetic factors on the pathology of Alzheimer's disease (AD) and Lewy body (LB) diseases, including Parkinson's disease and dementia with Lewy bodies. METHODS: A multicentre autopsy series (762 brain samples) with AD, LB or vascular pathology was examined. The effects of the tau gene (MAPT) H1 haplotype, the H1 specific SNP rs242557, APOE and the α-synuclein gene (SNCA) 3'UTR SNP rs356165 on the burden of AD and LB pathology were assessed. Neurofibrillary tangles (NFTs) were counted in four brain regions, senile plaques in five and LBs in four. Braak NFT stage, brain weight and presence of vascular pathology were also documented. RESULTS: MAPT H1 associated with lower counts of NFTs in the middle frontal (p<0.001) and inferior parietal (p=0.005) cortices, and also with lower counts of senile plaques in the motor cortex (p=0.001). Associations of MAPT H1 with increased LB counts in the middle frontal cortex (p=0.011) and inferior parietal cortex (p=0.033) were observed but were not significant after multiple testing adjustment. The APOE ε4 allele was strongly associated with overall Alzheimer type pathology (all p≤0.001). SNCA rs356165 and the MAPT H1 specific SNP rs242557 did not associate with AD or LB pathology. CONCLUSION: This study shows for the first time that MAPT H1 is associated with reduced Alzheimer type pathology which could have important implications for the understanding of disease mechanisms and their genetic determinants.
PURPOSE: The study investigates the effects of genetic factors on the pathology of Alzheimer's disease (AD) and Lewy body (LB) diseases, including Parkinson's disease and dementia with Lewy bodies. METHODS: A multicentre autopsy series (762 brain samples) with AD, LB or vascular pathology was examined. The effects of the tau gene (MAPT) H1 haplotype, the H1 specific SNP rs242557, APOE and the α-synuclein gene (SNCA) 3'UTR SNP rs356165 on the burden of AD and LB pathology were assessed. Neurofibrillary tangles (NFTs) were counted in four brain regions, senile plaques in five and LBs in four. Braak NFT stage, brain weight and presence of vascular pathology were also documented. RESULTS:MAPT H1 associated with lower counts of NFTs in the middle frontal (p<0.001) and inferior parietal (p=0.005) cortices, and also with lower counts of senile plaques in the motor cortex (p=0.001). Associations of MAPT H1 with increased LB counts in the middle frontal cortex (p=0.011) and inferior parietal cortex (p=0.033) were observed but were not significant after multiple testing adjustment. The APOE ε4 allele was strongly associated with overall Alzheimer type pathology (all p≤0.001). SNCArs356165 and the MAPT H1 specific SNP rs242557 did not associate with AD or LB pathology. CONCLUSION: This study shows for the first time that MAPT H1 is associated with reduced Alzheimer type pathology which could have important implications for the understanding of disease mechanisms and their genetic determinants.
Authors: Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee Journal: Science Date: 2003-04-25 Impact factor: 47.728
Authors: Irina Mikolaenko; Olga Pletnikova; Claudia H Kawas; Richard O'Brien; Susan M Resnick; Barbara Crain; Juan C Troncoso Journal: J Neuropathol Exp Neurol Date: 2005-02 Impact factor: 3.685
Authors: John B J Kwok; Erdahl T Teber; Clement Loy; Marianne Hallupp; Garth Nicholson; George D Mellick; Daniel D Buchanan; Peter A Silburn; Peter R Schofield Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: T Polvikoski; R Sulkava; M Haltia; K Kainulainen; A Vuorio; A Verkkoniemi; L Niinistö; P Halonen; K Kontula Journal: N Engl J Med Date: 1995-11-09 Impact factor: 91.245
Authors: Corey T McMillan; Jon B Toledo; Brian B Avants; Philip A Cook; Elisabeth M Wood; Eunran Suh; David J Irwin; John Powers; Christopher Olm; Lauren Elman; Leo McCluskey; Gerard D Schellenberg; Virginia M-Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman Journal: Neurobiol Aging Date: 2013-12-02 Impact factor: 4.673
Authors: Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson Journal: Acta Neuropathol Date: 2012-11-04 Impact factor: 17.088
Authors: Michael G Heckman; Koji Kasanuki; Nancy N Diehl; Shunsuke Koga; Alexandra Soto; Melissa E Murray; Dennis W Dickson; Owen A Ross Journal: Parkinsonism Relat Disord Date: 2017-09-11 Impact factor: 4.891
Authors: Shunsuke Koga; Monica Sanchez-Contreras; Keith A Josephs; Ryan J Uitti; Neill Graff-Radford; Jay A van Gerpen; William P Cheshire; Zbigniew K Wszolek; Rosa Rademakers; Dennis W Dickson Journal: Mov Disord Date: 2016-12-23 Impact factor: 10.338
Authors: Daphne Robakis; Etty Cortes; Lorraine N Clark; Jean Paul G Vonsattel; Tuhin Virmani; Roy N Alcalay; John F Crary; Oren A Levy Journal: J Neural Transm (Vienna) Date: 2016-04-20 Impact factor: 3.575
Authors: Michel J Grothe; Christina Schuster; Florian Bauer; Helmut Heinsen; Johannes Prudlo; Stefan J Teipel Journal: J Neurol Date: 2014-07-25 Impact factor: 4.849